Show All
Where is Design Therapeutics’ corporate headquarters?

Design Therapeutics is headquartered at
6005 Hidden Valley Road,
Suite 110 Carlsbad,
California, 92011

When was the company founded?
Design Therapeutics was founded and commenced operations in 2017.
When did Design Therapeutics go public?
Design Therapeutics’ initial public offering (IPO) occurred on March 26, 2021.
When is Design Therapeutics’ fiscal year-end?
Design Therapeutics’ fiscal year ends on December 31st.
How is Design Therapeutics’ stock traded?
Design Therapeutics is traded on the NASDAQ Global Market under the ticker symbol DSGN, and its CUSIP number is 0001807120.
Who is Design Therapeutics’ transfer agent?
American Stock Transfer and Trust Company
59 Maiden Lane
New York, NY 10038
Attn: Shareholder Services
(718) 921-8124 or (800) 937-5449
Who are Design Therapeutics’ independent auditors?

Ernst & Young LLP
4365 Executive Dr # 1600
San Diego, CA 92121

Who is Design Therapeutics’ legal counsel?
Cooley LLP 4401
Eastgate Mall
San Diego, California 92121
(858) 550-6000
Where can I get the latest corporate news releases and financial reports?
Design Therapeutics’ press release archives can be viewed at the news releases page
How can I view documents Design Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Design Therapeutics’ SEC filings can be viewed at this page
Whom should I contact if I have further questions?
You can submit queries to Design Therapeutics’ investor relations department by contacting